Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse

Neuroscience

Volumn 85, Issue 1, 1998, Pages 93-110

  Anderson, R ^a   Barnes, J C ^a   Bliss, T V P ^b   Cain, D P ^c   Cambon, K ^d   Davies, H A ^d   Errington, M L ^b   Fellows, L A ^a   Gray, R A ^a   Hoh, T ^c   Stewart, M ^d   Large, C H ^a   Higgins, G A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d OPEN UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cognition; LTP; Plasticity; Repair

Indexed keywords

APOLIPOPROTEIN E; MICROTUBULE ASSOCIATED PROTEIN 2; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GENE DELETION; IMMUNOHISTOCHEMISTRY; KINDLING; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; SYNAPSE;

ANIMALS; APOLIPOPROTEINS E; BEHAVIOR, ANIMAL; DENTATE GYRUS; ELECTROPHYSIOLOGY; ENTORHINAL CORTEX; GAP-43 PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KINDLING, NEUROLOGIC; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; SYNAPSES; SYNAPTOPHYSIN;

EID: 0031971420     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00598-8     Document Type: Article

References (82)

1. Anderson R., Higgins G. A. Absence of central cholinergic deficits in ApoE knockout mice. Psychopharmacology. 132:1997;135-144.
2. Arendt T., Schindler C., Bruckner M. K., Eschrich K., Bigl V., Zedlick D., Marcova L. Plastic neuronal remodelling is impaired in patients with Alzheimer's disease carrying apolipoprotein E4 allele. J. Neurosci. 17:1997;516-529.
3. Baribault H., Penner J., Iozzo R., Wilson-Heiner M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8:1994;2964-2973.
4. Bliss T. V. P., Collingridge G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
5. Boyles J. K., Zoellner C. D., Anderson L. J., Kosik L. M., Pitas R. E., Weisgraber K. H., Hui D. Y., Mahley R. W., Gebicke-Haerter P. J., Ignatius M. J., Shooter E. M. A role for apolipoprotein E, apolipoprotein A-1, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the sciatic nerve. J. clin. Invest. 83:1989;1015-1031.
6. Cain D. P. Long-term potentiation and kindling: how similar are the mechanisms? Trends Neurosci. 12:1989;6-10.
7. Cain D. P., Corcoran M. E., Staines W. A. Effects of protein synthesis inhibition on kindling in the mouse. Expl Neurol. 68:1980;409-419.
8. Cain D. P., Grant S. G. N., Saucier D., Hargreaves E. L., Kandel E. R. Fyn tyrosine kinase is required for normal amygdala kindling. Epilepsy Res. 22:1995;107-114.
9. Chen Y., Lomnitski L., Michaelson D. M., Shohami E. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience. 80:1997;1255-1262.
10. Corder E. H., Saunders A. M., Strittmater W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
11. Crawley J. N., Belknap J. K., Collins A., Crabbe J. C., Frankel W., Henderson N., Hitzemann R. J., Maxson S. C., Miner L. L., Silva A. J., Wehner J. M., Wynshaw-Boris A., Paylor R. Behavioural phenotypes of inbred mouse strains: implications and recommendations. Psychopharmacology. 132:1997;107-124.
12. Dennison Z., Teskey G. C., Cain D. P. Persistence of kindling: effect of partial kindling, kindling site, and stimulation parameters. Epilepsy Res. 21:1995;171-182.
13. Edwards F. A. Anatomy and electrophysiology of fast central synapses lead to a structural model for long-term potentiation. Neurosci. Rev. 75:1995;759-787.
14. Errington M. L., Bliss T. V. P., Morris R. J., Laroche S., Davis S. Long-term potentiation in awake mutant mice. Nature. 387:1997;666-667.
15. Fazeli M. S., Cobet J., Dunn M. J., Dolphin A. C., Bliss T. V. P. Changes in protein synthesis accompanying long-term potentiation in the dentate gyrus in vivo. J. Neurosci. 13:1993;1346-1353.
16. Gandy S., Stafstrom C., Turner B., Sweeney D., Breslow J., Greengard P., Smith J., Ouimet C. Aged ApoE deficient mice: abnormal learning and glial markers but no obvious neuropathology. Soc. Neurosci. Abstr. 21:1995;9.3.
17. Gehrmann J., Matsumato Y., Kreutzberg G. W. Microglia: intrinsic immunoeffector cell in the brain. Brain Res. Rev. 20:1995;269-287.
18. Gerlai R. Gene-targeting studies of mammalian behaviour: is it the mutation or the background genotype? Trends Neurosci. 19:1996;177-189.
19. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D. M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
20. Hardman R., Evans D. J., Fellows L., Hayes B., Rupniak H. T., Barnes J. C., Higgins G. A. Evidence for recovery of spatial learning following entorhinal cortex lesions in mice. Brain Res. 758:1997;187-200.
21. Higgins G. A., Anderson R., Fellows L., Collins F. C., Beesley J., Arban R., Pietra C., Barnes J. C. Transgenic approaches to studying the role of ApoE. Soc. Neurosci. Abstr. 23:1997;323.7.
22. Higgins G. A., Large C. H., Rupniak H. T., Barnes J. C. Apolipoprotein E and Alzheimer's disease: a review of recent studies. Pharmac. Biochem. Behav. 56:1997;675-685.
23. Holtzman D. M., Pitas R. E., Kilbridge J., Nathan B., Mahley R. W., Bu G., Schwartz A. L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. natn. Acad. Sci. U.S.A. 92:1995;9480-9484.
24. Hsaio K. K., Borchelt D. R., Olson K., Johansdottir R., Kitt C., Yunis W., Xu S., Eckman C., Younkin S., Price D., Iadecola C., Clark H. B., Carlson G. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1203-1218.
25. Ignatius M. J., Gebicke-Haerter P. J., Skene J. H. P., Schilling K. H., Weisgraber K. H., Mahley R. W., Shooter E. M. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. natn. Acad. Sci. U.S.A. 83:1986;1125-1129.
26. Jenne D. E., Tschopp J. Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends biochem. Sci. 17:1992;154-159.
27. Katz B., Miledi R. The role of calcium in neuromuscular facilitation. J. Physiol. 195:1968;481-492.
28. Kida E., Pluta R., Lossinsky A. S., Golabek A. A., Choi-Miura N.-H., Wisniewski H. M., Mossakowski M. J. Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res. 674:1995;341-346.
29. Lampert-Etchells M., McNeill T. H., Laping N. J., Zarow C., Finch C. E., May P. C. Sulfated glycoprotein-2 is increased in rat hippocampus following entorhinal cortex lesioning. Brain Res. 563:1991;101-106.
30. Laskowitz D. T., Goel S., Bennett E. R., Matthew W. D. Apolipoprotein E suppresses glial secretion of TNFα J. Neuroimmun. 76:1997;70-74.
31. Laskowitz D. T., Sheng H., Bart R. D., Joyner K. A., Roses A. D., Warner D. S. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischaemia. J. cerebr. Blood Flow Metab. 17:1997;753-758.
32. Leech C. K., McIntyre D. C. Kindling rates in inbred mice: an analog to learning? Behav. Biol. 16:1976;439-452.
33. Logue S. F., Owen E. H., Rasmussen D. L., Wehner J. M. Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids: implications of genetic background for single gene and quantitative trait loci analyses. Neuroscience. 80:1997;1075-1086.
34. Lomnitski L., Kohen R., Chen Y., Shohami E., Trembovler V., Vogel T., Michaelson D. M. Reduced levels of antioxidants in brains of apolipoprotein E-deficient mice following closed head injury. Pharmac. Biochem. Behav. 56:1997;669-673.
35. Lynch G., Gall C., Rose G., Cotman C. Changes in the distribution of the dentate gyrus associational system following unilateral or bilateral entorhinal lesions in the adult rat. Brain Res. 110:1976;57-71.
36. Lynch G., Matthews S., Mosko T., Parks T., Cotman C. Induced acetylcholinesterase-rich layer in rat dentate gyrus following entorhinal lesions. Brain Res. 42:1972;311-318.
37. Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
38. Malenka R. C., Nicoll R. A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 16:1993;521-527.
39. Martel C. L., Ghiso J., Frangione B., Zlokovic B. V. Transport of apolipoproteins E and J at the blood brain barrier - relevance to Alzheimer's disease. S.T.P. pharmac. Sci. 7:1997;28-36.
40. Masliah E., Fagan R. D., Terry R., DeTeresea R., Mallory M., Gage F. H. Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Expl Neurol. 113:1991;131-142.
41. Masliah E., Mallory M., Alford M., Ge N. and Mucke L. (1995) Abnormal synaptic regeneration in hAPP695 transgenic and ApoE knockout mice. In Research Advances in Alzheimer's Disease and Related Disorders (eds Iqbal K. et al.), pp. 405-414. John Wiley, New York.
42. Masliah E., Mallory M., Alford M., Veinberg I. and Roses A. D. (1996) Apolipoprotein E's role in maintaining the integrity of the aging central nervous system. In Apolipoprotein E and Alzheimer's Disease (eds Roses A. D. et al.), pp. 59-71. Springer, Berlin.
43. Masliah E., Mallory M., Ge N., Alford M., Veinberg I., Roses A. D. Neurodegeneration in the central nervous system of apoE-deficient mice. Expl Neurol. 136:1995;107-122.
44. Masliah E., Samuel W., Veinbergs I., Mallory M., Mante M., Saitoh T. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 751:1997;307-314.
45. May P. C., Lampert-Etchells M., Johnson S. A., Poirier J., Masters J. N., Finch C. E. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in experimental lesions in rat. Neuron. 5:1990;831-839.
46. Miyata M., Smith J. D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nature Genet. 14:1996;55-61.
47. Morris R. G. M. Spatial localisation does not require the presence of local cues. Learning Motiv. 12:1981;239-249.
48. Morris R. G. M. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 11:1984;47-60.
49. Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., Pitas R. E. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
50. Nathan B. P., Chang K.-C., Bellosta S., Brisch E., Ge N., Mahley R. W., Pitas R. E. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerisation. J. biol. Chem. 270:1995;19791-19799.
51. Nosten-Bertrand M., Errington M. L., Murphy K. P., Tokugawa Y., Barboni E., Kozlova E., Michalovich D., Morris R. G., Silver J., Stewart C. L., Bliss T. V., Morris R. J. Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1. Nature. 379:1996;826-829.
52. Oitzl M. S., Mulder M., Lucassen P. J., Havekes L. M., Grootendorst J., de Kloet E. R. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res. 752:1997;189-196.
53. Otani S., Marshall C. J., Tate W. P., Goddard G. V., Abraham W. C. Maintenance of long-term potentiation in rat dentate gyrus requires protein synthesis but not messenger RNA synthesis immediately post-tetanization. Neuroscience. 28:1989;519-526.
54. Owen E. H., Logue S. F., Rasmussen D. L., Wehner J. M. Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience. 80:1997;1087-1099.
55. Parker C. A., Callahan M. J., Lipinski W. J., Bisgaier C. L. and Walker L. C. (1996) Effects of aging on glial and neural markers in apolipoprotein E-deficient mice. Soc. Neurosci. Abstr. 22, 86.3, 207.
56. Perry V. H., Andersson P.-B., Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16:1993;268-272.
57. Peuchen S., Bolanos J. P., Heales S. J. R., Almeida A., Duchen M. R., Clark J. B. Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Prog. Neurobiol. 52:1997;261-281.
58. Piedrahita J. A., Zhang S. H., Hagaman J. R., Oliver P. M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. natn. Acad. Sci. U.S.A. 89:1992;4471-4475.
59. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L. Severe hypercholesterolaemia and atheroscelerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
60. Poirier J. Apolipoprotein E in animal models of CNS injury and Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
61. Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience. 55:1993;81-90.
62. Poirier J., Hess M., May P. C., Finch C. E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Molec. Brain Res. 11:1991;97-106.
63. Popko B., Goodrum J. F., Bouldin T. W., Zhang S. H., Maeda N. Nerve regeneration occurs in the absence of apolipoprotein E in mice. J. Neurochem. 60:1993;1155-1158.
64. Puttfarcken P. S., Manelli A. M., Falduto M. T., Getz G. S., LaDu M. J. Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures. J. Neurochem. 68:1997;760-769.
65. Racine R. J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroenceph. clin. Neurophysiol. 32:1972;281-294.
66. Robinson G. B., Racine R. J. Heterosynaptic interactions between septal and entorhinal inputs to the dentate gyrus: long term potentiation effects. Brain Res. 249:1982;162-166.
67. Rose S. The rise of neurogenetic determinism. Nature. 373:1995;380-382.
68. Sato M., Racine R. J., McIntyre D. C. Kindling: basic mechanisms and clinical validity. Electroenceph. clin. Neurophysiol. 76:1990;459-472.
69. Saunders A. M., Strittmater W. J., Schmechel D., St. George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gussella J. F., Crapper-McLachlan D., Alberts M. J., Hulette C., Crain B., Goldgaber D., Roses A. D. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
70. Schauwecker P. E., Steward O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targetting approaches. Proc. natn. Acad. Sci. U.S.A. 94:1997;4103-4108.
71. Schauwecker P. E., Steward O. Genetic influences on cellular reactions to brain injury - activation of microglia in denervated neurophil in mice carrying a mutation (WLD(S)) that causes delayed Wallerian degeneration. J. comp. Neurol. 380:1997;82-94.
72. Schneider J. A., Gearing M., Robbins R. S., de L'Aune W., Mirra S. S. Apolipoprotein genotype in diverse neurodegenerative disorders. Ann. Neurol. 38:1995;131-135.
73. Smithies O., Maeda N. Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc. natn. Acad. Sci. U.S.A. 92:1995;5266-5272.
74. Sterio D. C. The unbiased estimation of number and size of arbitrary particles using the dissector. J. Microsc. 134:1984;127-136.
75. Steward O., Trimmer P. A. Genetic influences on cellular reactions to CNS injury: the reactive response of astrocytes in denervated neurophil regions in mice carrying a mutation (Wlds) that causes delayed Wallerian degeneration. J. comp. Neurol. 380:1997;70-81.
76. Strittmater W. J., Weisgraber K. H., Goedert M., Saunders A. M., Huang D., Corder E. H., Dong L. M., Jakes R., Alberts M. J., Gilbert J. R., Roses A. D. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer's disease brain are related to apoliprotein E genotype. Expl Neurol. 125:1994;163-171.
77. Strittmater W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D. E., Saunders A. M., Goldgaber D., Roses A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform specific effects and implications for late onset Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 90:1993;8098-8102.
78. Teyler T. J., DiScenna P. Long-term potentiation. A. Rev. Neurosci. 10:1987;131-161.
79. Van Ree J. H., Van den Broek W. J. A. A., Dahlmans V. E. H., Groot P. H. E., Vidgeon-Hart M., Frants R. R., Wieringa B., Havekes L. M., Hofker M. H. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis. 111:1994;25-37.
80. Weisgraber K. H. Apolipoprotein E: structure function relationships. Adv. Protein Chem. 45:1994;249-299.
81. Xu P.-T., Schmechel D., Rothrock-Christian T., Scott Burkhart D., Qiu H.-L., Popko B., Sullivan P., Maeda N., Saunders A. M., Roses A. D., Gilbert J. R. Human apolipoprotein E2, E3 and E4 isoform specific transgenic mice: human-like pattern of neuronal immunoreactivity in central nervous system not observed in wild type mice. Neurobiol. Dis. 3:1996;229-245.
82. Zhang S. H., Reddick R. L., Piedrahita J. A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.